OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • The OncLive Insider app is live!
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

New Treatment Options for Rare Diseases in the Soft Tissue

home / news-network / rare-diseases-in-the-soft-tissue
Diagnostic Testing Procedure for Soft Tissue Sarcoma

EP. 1: Diagnostic Testing Procedure for Soft Tissue Sarcoma

March 25th 2020
Current Treatment Landscape of Soft Tissue Sarcoma

EP. 2: Current Treatment Landscape of Soft Tissue Sarcoma

March 25th 2020
Switching Therapy: Secondary Mutations and Resistance

EP. 3: Switching Therapy: Secondary Mutations and Resistance

March 25th 2020
The Prognostic Value of Molecular Testing

EP. 4: The Prognostic Value of Molecular Testing

March 25th 2020
Soft Tissue Sarcoma: Unmet Needs

EP. 5: Soft Tissue Sarcoma: Unmet Needs

March 25th 2020
Targeted Therapy Advancements in Sarcoma Subtypes

EP. 6: Targeted Therapy Advancements in Sarcoma Subtypes

March 25th 2020
Use of Targeted Therapy in GIST Mutations

EP. 7: Use of Targeted Therapy in GIST Mutations

March 25th 2020
GIST Treatment: Durability of Response and Challenges

EP. 8: GIST Treatment: Durability of Response and Challenges

March 25th 2020
The Future of Treatment for Soft Tissue Diseases

EP. 9: The Future of Treatment for Soft Tissue Diseases

March 25th 2020

Latest Conference Coverage

Venetoclax/DEC-C Is Potential New SOC in Newly Diagnosed AML Ineligible for Intensive Chemo

Revumenib-Based Triplet Is Safe, Highly Active in Older/Unfit NMP1/KMT2A-Altered AML

Dr Skrypets on an Analysis of Clinical Features of Older Patients With PTCL

Olaparib/Temozolomide Fails to Meet PFS End Point in Previously Treated Advanced Uterine Leiomyosarcoma

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact